Rare
lephants
Screener
Toggle theme
Cadre Holdings, Inc.
CDRE
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Total Cash from Operations:
$73.9M
Line Item
Value
% of Total
Capital Expenditures
$6.7M
9.1%
Dividends Paid
$12.0M
16.3%
Other Financing
$12.7M
17.2%
Net Cash Flow
$42.4M
57.4%
Download CSV
